ArticleOncogene2022

Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism.

Kentaro Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.